Brown Advisory’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,243
Closed -$237K 1252
2023
Q4
$237K Sell
2,243
-74
-3% -$7.46K ﹤0.01% 1121
2023
Q3
$252K Buy
2,317
+58
+3% +$6.42K ﹤0.01% 1053
2023
Q2
$244K Buy
+2,259
New +$254K ﹤0.01% 1071
2022
Q1
Sell
-905
Closed -$233K 1125
2021
Q4
$233K Hold
905
﹤0.01% 1127
2021
Q3
$247K Buy
+905
New +$288K ﹤0.01% 999

Other funds holding BNTX

Brown Advisory's BNTX Position: Q1 2024 in Review

Brown Advisory sold out of BioNTech (BNTX) in Q1 2024, closing a stake of 2,243 shares — an estimated $237K sold.

Brown Advisory first reported a position in BNTX in Q3 2021 and held it in 5 quarters. The position peaked at $252K in Q3 2023. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2024.

  • Brown Advisory reported no remaining BioNTech position as of Q1 2024 after selling out during the quarter.
  • Brown Advisory sold 2,243 BioNTech shares in Q1 2024, an estimated $237K.
  • Brown Advisory first reported a position in BioNTech in Q3 2021 and held it in 5 quarters.
  • Brown Advisory's BioNTech position peaked at $252K in Q3 2023.
  • 287 funds tracked by Wall St. Rank held BioNTech as of Q1 2024.

Based on Brown Advisory's 13F filing for Q1 2024, filed 24 Apr 2024.